ditercalinium has been researched along with Glioma in 1 studies
ditercalinium: structure given in first source; RN given refers to parent cpd
Glioma: Benign and malignant central nervous system neoplasms derived from glial cells (i.e., astrocytes, oligodendrocytes, and ependymocytes). Astrocytes may give rise to astrocytomas (ASTROCYTOMA) or glioblastoma multiforme (see GLIOBLASTOMA). Oligodendrocytes give rise to oligodendrogliomas (OLIGODENDROGLIOMA) and ependymocytes may undergo transformation to become EPENDYMOMA; CHOROID PLEXUS NEOPLASMS; or colloid cysts of the third ventricle. (From Escourolle et al., Manual of Basic Neuropathology, 2nd ed, p21)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Le Moyec, L | 1 |
| Naruse, S | 1 |
| Higuchi, T | 1 |
| Hirakawa, K | 1 |
| Watari, H | 1 |
| de Certaines, JD | 1 |
| Roques, BP | 1 |
1 other study available for ditercalinium and Glioma
| Article | Year |
|---|---|
In vivo 31P MRS in new antineoplastic agents evaluation on experimental tumor models.
Topics: Animals; Antineoplastic Agents; Carbazoles; Carcinoma 256, Walker; Energy Metabolism; Female; Glioma | 1988 |